Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia - The NASIMMUNE Study

NCT02972957 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.

NCT NCT02972957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02972957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia - The NASIMMUNE Study
Lead sponsor
London School of Hygiene and Tropical Medicine
Phase
Phase 4
Overall status
Completed
Start date
January 30, 2017
Completion date
May 23, 2019
Enrollment
364 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza